Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...
GlobalData on MSN2d
SmartCella gains rights to advance cell therapy research for Parkinson’sThe company signed the agreement with Karolinska Institutet's Department of Cell and Molecular Biology professor Johan ...
Q4 2024 Earnings Conference Call February 12, 2025 5:00 PM ETCompany ParticipantsJohn Saager - Vice President, ...
PHC has partnered with CCRM to boost cell quality with advanced T-cell expansion solutions. Takeaway Points PHC has ...
"We are excited to collaborat with PHC to unlock new possibilities in cell culture," explained Michael May, President and CEO ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...
“Using renewable electricity, 75 percent of that energy makes it to the wheels of a BEV,” says James Edmondson, research ...
Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...
Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025. At this time, all participants have been placed in a listen-only mode and the call will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback